The role of AI and machine learning in optimizing insulin therapy: a comparative study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20250938Keywords:
Artificial intelligence, Machine learning, Insulin optimization, Diabetes care, Glycemic control, HypoglycemiaAbstract
Managing diabetes effectively requires precise insulin dosing. AI and ML have emerged as valuable tools in optimizing insulin therapy. This study compares AI/ML-based insulin optimization with standard therapy to assess its impact on glycemic control and patient satisfaction. A quasi-experimental study was conducted involving 100 patients divided into AI-assisted and standard insulin therapy groups. Primary outcomes measured included HbA1c levels and frequency of hypoglycemic episodes, while secondary outcomes included patient satisfaction and adherence rates. Statistical tests such as paired t-tests, chi-square tests, and ANOVA were applied. Patients in the AI-assisted therapy group exhibited a significant reduction in HbA1c levels (p<0.05), fewer hypoglycemic episodes (p<0.05), and higher satisfaction levels (p<0.05) compared to the standard therapy group. AI and ML-based insulin optimization improve glycemic control, reduce hypoglycemia, and enhance patient satisfaction, making it a valuable addition to diabetes management strategies.
Metrics
References
Karanth S, Shruthi K, Sheela CN, Ross C. Prevalence of thrombocytopenia in Parturient: Experience in Tertiary Care Center. Indian J Obst and Gynecol Res. 2023;5(1):98-103. DOI: https://doi.org/10.18231/2394-2754.2018.0022
Heinemann L, Deiss D, Siegmund T, Schlüter S, Naudorf M, von Sengbusch S, et al. Glucose measurement and control in patients with type 1 or type 2 diabetes. Experimental and Clinical Endocrinology & Diabetes. 2019;127(1):8-26. DOI: https://doi.org/10.1055/a-1018-9090
He J, Baxter SL, Xu J, Xu J, Zhou X, Zhang K. The practical implementation of artificial intelligence technologies in medicine. Nature Med. 2019;25(1):30-6. DOI: https://doi.org/10.1038/s41591-018-0307-0
Shrestha N. Use of artificial intelligence in public health. J of Chitwan Medical College. 2024;14(1):1-4. DOI: https://doi.org/10.54530/jcmc.1482
Zale A, Mathioudakis N. Machine learning models for inpatient glucose prediction. Current Diabetes Reports. 2022;22(8):353-64. DOI: https://doi.org/10.1007/s11892-022-01477-w
Bergenstal RM, Tamborlane WV. Benefits of real-time continuous glucose monitoring in diabetes management. JAMA. 2020;2:23-38.
Alam MA, Sohel A, Hasan KM, Islam MA. Machine learning and artificial intelligence in diabetes prediction and management: a comprehensive review of models. J of Next-Gen Engineering Systems. 2024;30:3828. DOI: https://doi.org/10.70937/jnes.v1i01.41
Giorgini F, Di Dalmazi G, Diciotti S. Artificial intelligence in endocrinology: a comprehensive review. J Endocrinol Invest. 2024;47(5):1067-82. DOI: https://doi.org/10.1007/s40618-023-02235-9
American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care, 2023.
Poonguzhali S, Chakravarthi R. A sensor based intelligent system for classification and assistance of diabetes patients in telemedicine technology. J of Intelligent & Fuzzy Systems. 2021;40(4):6365-74. DOI: https://doi.org/10.3233/JIFS-189477
Beets B, Newman TP, Howell EL, Bao L, Yang S. Surveying public perceptions of artificial intelligence in health care in the United States: systematic review. J Med Internet Res. 2023;25:40337. DOI: https://doi.org/10.2196/40337
Guan Z, Li H, Liu R, Cai C. Artificial intelligence in diabetes management: advancements, opportunities, and challenges. Cell Reports Medicine. 2023;4(10):53. DOI: https://doi.org/10.1016/j.xcrm.2023.101213
Chai SS, Goh KL, Cheah WL, Chang YH, Ng GW. Hypertension prediction in adolescents using anthropometric measurements: do machine learning models perform equally well. Applied Sciences. 2022;12(3):1600. DOI: https://doi.org/10.3390/app12031600
Downloads
Published
How to Cite
Issue
Section
